FDA Investigator: Qiao Y. Bobo

- Qiao Y. Bobo first started conducting FDA inspections in 2010, with the last inspection in 2024. Over that time, Qiao Y. Bobo has conducted 11 inspections at 11 companies across 11 sites.

Get Qiao Bobo's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Hainan Shuangcheng Pharmaceuticals Co Ltd, Hainansheng | 2024

Out-of-stock
Qiao Y. Bobo
Human Drugs Form 483

FDA 483 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site), Lianyungang | 2024

Out-of-stock
Qiao Y. Bobo
Human Drugs Form 483

FDA 483 Abraham J & Phyllis Katz Cord Blood Foundation, Cleveland | 2015

Out-of-stock
Qiao Y. Bobo
Biologic Form 483

FDA 483 Ipsen BioPharm Ltd, Wrexham | 2014

Out-of-stock
Qiao Y. Bobo
Biologic Form 483

FDA 483 Baxalta US Inc., Milford | 2014

Out-of-stock
Qiao Y. Bobo
Biologic Form 483

FDA 483 Baxter Manufacturing S.p.A., Rieti | 2012

Out-of-stock
Qiao Y. Bobo
Biologic Form 483

FDA 483 Organogenesis, Inc., Canton | 2011

Out-of-stock
Qiao Y. Bobo
Biologic Form 483

FDA 483 GlaxoSmithKline Biologicals, Dresden | 2011

Out-of-stock
Qiao Y. Bobo
Biologic Form 483

FDA 483 Ortho-Clinical Diagnostics, Inc., Raritan | 2010

Out-of-stock
Qiao Y. Bobo
Biologic Form 483

FDA 483 Maxim Biomedical Incorporated, Rockville | 2010

Out-of-stock
Qiao Y. Bobo
Biologic Form 483